CX3CR1 and Alzheimer disease: These findings suggest that slight downregulation of CX3CR1 activity might be enough to influence neuron-microglia communication, restore neuronal Aβ-degrading enzymes, and ultimately slow the progression of AD-like pathology in APPPS1 mice (Hickman et al., 2019).